V

Verve Therapeutics

236 employees

Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Genetics
Life Science

Date founded

2018

Funding rounds raised

Total raised

$94M

from 16 investors over 16 rounds

V

Verve Therapeutics raised $94M on January 19, 2021

Investors: GV, Wellington Management, Redmile Group, Novo Holdings, Logos Global Management, LP, Surveyor Capital and RA Capital Management, L.P.

V

Verve Therapeutics raised $63M on June 11, 2020

Investors: Biomatics Capital, ARCH Venture Partners, F-Prime Capital Partners, Casdin Capital, LLC, GV and Wellington Management

V

Verve Therapeutics raised $59M on May 7, 2019

Investors: ARCH Venture Partners, GV and F-Prime Capital Partners

FAQ